Editorial
World J Gastroenterol
31(10):101838.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101838
Abstract (149)
|
Core Tip (134)
|
Full Article (HTML) (883)
|
Full Article (PDF)-378K (69)
|
Full Article with Cover (PDF)-633K (42)
|
Full Article (XML)-71K (25)
|
Audio-3309K (9)
|
Peer-Review Report-245K (29)
|
Answering Reviewers-157K (30)
|
Received: 09/28/2024
|
Revised: 01/23/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1594)
|
Similar Articles (138)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches

World J Gastroenterol
31(10):102289.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102289
Abstract (154)
|
Core Tip (135)
|
Full Article (HTML) (1491)
|
Figures (1-1) (146)
|
Tables (1-3) (119)
|
Full Article (PDF)-4025K (183)
|
Full Article with Cover (PDF)-4275K (38)
|
Full Article (XML)-507K (19)
|
Audio-1047K (18)
|
Peer-Review Report-271K (24)
|
Answering Reviewers-120K (34)
|
Received: 10/13/2024
|
Revised: 11/28/2024
|
Accepted: 01/17/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2848)
|
Similar Articles (333)
|
Timeline of Article Publication (10)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
World J Gastroenterol
31(10):103454.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103454
Abstract (157)
|
Core Tip (159)
|
Full Article (HTML) (974)
|
Figures (1-1) (129)
|
Full Article (PDF)-1122K (65)
|
Full Article with Cover (PDF)-1376K (31)
|
Full Article (XML)-113K (21)
|
Audio-412K (13)
|
Peer-Review Report-223K (30)
|
Answering Reviewers-109K (24)
|
Received: 11/20/2024
|
Revised: 12/31/2024
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2121)
|
Similar Articles (1734)
|
Timeline of Article Publication (7)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Control Study
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes

World J Gastroenterol
31(10):103716.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103716
Abstract (156)
|
Core Tip (149)
|
Full Article (HTML) (762)
|
Figures (1-1) (127)
|
Tables (1-6) (125)
|
Full Article (PDF)-876K (47)
|
Full Article with Cover (PDF)-1130K (22)
|
Full Article (XML)-191K (18)
|
Audio-454K (14)
|
Peer-Review Report-229K (25)
|
Answering Reviewers-124K (20)
|
Supplementary Material-657K (26)
|
Received: 11/27/2024
|
Revised: 01/16/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1962)
|
Similar Articles (28)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Endoscopic full-thickness resection: A definitive solution for local complete resection of small rectal neuroendocrine neoplasms

World J Gastroenterol
31(10):100444.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100444
Abstract (173)
|
Core Tip (162)
|
Full Article (HTML) (830)
|
Figures (1-4) (138)
|
Tables (1-3) (153)
|
Full Article (PDF)-8140K (64)
|
Full Article with Cover (PDF)-8392K (34)
|
Full Article (XML)-121K (23)
|
Audio-885K (22)
|
Peer-Review Report-197K (31)
|
Answering Reviewers-155K (27)
|
Supplementary Material-123K (26)
|
Received: 08/16/2024
|
Revised: 12/11/2024
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2398)
|
Similar Articles (16)
|
Timeline of Article Publication (7)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Gastroenterol
31(10):102393.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102393
Abstract (146)
|
Core Tip (142)
|
Full Article (HTML) (772)
|
Figures (1-2) (137)
|
Tables (1-3) (140)
|
Full Article (PDF)-3168K (61)
|
Full Article with Cover (PDF)-3422K (31)
|
Full Article (XML)-97K (25)
|
Audio-586K (16)
|
Peer-Review Report-221K (39)
|
Answering Reviewers-311K (32)
|
Supplementary Material-128K (37)
|
Received: 10/16/2024
|
Revised: 01/04/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2292)
|
Similar Articles (3)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Circular RNA contributes to gastric cancer by targeting Wnt family member 2B as a competing endogenous RNA

World J Gastroenterol
31(10):99583.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.99583
Abstract (150)
|
Core Tip (145)
|
Full Article (HTML) (613)
|
Figures (1-6) (144)
|
Full Article (PDF)-10367K (45)
|
Full Article with Cover (PDF)-10622K (52)
|
Full Article (XML)-108K (21)
|
Audio-200K (10)
|
Peer-Review Report-203K (29)
|
Answering Reviewers-316K (50)
|
Received: 10/23/2024
|
Revised: 12/26/2024
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1425)
|
Similar Articles (1151)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathway

World J Gastroenterol
31(10):100194.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100194
Abstract (147)
|
Core Tip (146)
|
Full Article (HTML) (719)
|
Figures (1-8) (158)
|
Full Article (PDF)-42475K (61)
|
Full Article with Cover (PDF)-42729K (24)
|
Full Article (XML)-113K (16)
|
Audio-352K (12)
|
Peer-Review Report-309K (21)
|
Answering Reviewers-116K (24)
|
Supplementary Material-190K (23)
|
Received: 08/09/2024
|
Revised: 12/16/2024
|
Accepted: 01/21/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1586)
|
Similar Articles (138)
|
Timeline of Article Publication (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption

World J Gastroenterol
31(10):101014.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101014
Abstract (134)
|
Core Tip (139)
|
Full Article (HTML) (706)
|
Figures (1-6) (149)
|
Tables (1-1) (128)
|
Full Article (PDF)-10815K (53)
|
Full Article with Cover (PDF)-11065K (30)
|
Full Article (XML)-143K (21)
|
Audio-400K (12)
|
Peer-Review Report-253K (29)
|
Answering Reviewers-98K (29)
|
Supplementary Material-270K (34)
|
Received: 09/03/2024
|
Revised: 12/19/2024
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2059)
|
Similar Articles (18)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
SEL1L-mediated endoplasmic reticulum associated degradation inhibition suppresses proliferation and migration in Huh7 hepatocellular carcinoma cells

World J Gastroenterol
31(10):103133.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103133
Abstract (150)
|
Core Tip (147)
|
Full Article (HTML) (653)
|
Figures (1-7) (131)
|
Full Article (PDF)-9623K (55)
|
Full Article with Cover (PDF)-9876K (27)
|
Full Article (XML)-121K (18)
|
Audio-824K (12)
|
Peer-Review Report-275K (23)
|
Answering Reviewers-363K (28)
|
Supplementary Material-48K (24)
|
Received: 11/10/2024
|
Revised: 01/04/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1592)
|
Similar Articles (1716)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?

World J Gastroenterol
31(10):100771.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100771
Abstract (171)
|
Core Tip (159)
|
Full Article (HTML) (444)
|
Figures (1-1) (132)
|
Tables (1-2) (136)
|
Full Article (PDF)-471K (40)
|
Full Article with Cover (PDF)-728K (25)
|
Full Article (XML)-61K (18)
|
Audio-512K (14)
|
Peer-Review Report-257K (18)
|
Answering Reviewers-156K (27)
|
Received: 08/25/2024
|
Revised: 01/10/2025
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1341)
|
Similar Articles (24)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102580.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102580
Abstract (151)
|
Core Tip (154)
|
Full Article (HTML) (568)
|
Tables (1-1) (148)
|
Full Article (PDF)-370K (47)
|
Full Article with Cover (PDF)-625K (33)
|
Full Article (XML)-56K (18)
|
Audio-2970K (11)
|
Peer-Review Report-217K (25)
|
Answering Reviewers-149K (21)
|
Received: 10/22/2024
|
Revised: 01/16/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1356)
|
Similar Articles (161)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102725.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102725
Abstract (176)
|
Core Tip (151)
|
Full Article (HTML) (1087)
|
Figures (1-1) (138)
|
Full Article (PDF)-1500K (63)
|
Full Article with Cover (PDF)-1754K (30)
|
Full Article (XML)-97K (19)
|
Audio-476K (12)
|
Peer-Review Report-468K (20)
|
Answering Reviewers-1818K (23)
|
Received: 10/27/2024
|
Revised: 01/16/2025
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1899)
|
Similar Articles (221)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Treatment of intermediate-to-advanced unresectable hepatocellular carcinoma is shifting toward a multidisciplinary strategy that includes multiple modalities as needed

World J Gastroenterol
31(10):103420.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103420
Abstract (153)
|
Core Tip (148)
|
Full Article (HTML) (529)
|
Figures (1-1) (138)
|
Tables (1-1) (146)
|
Full Article (PDF)-578K (45)
|
Full Article with Cover (PDF)-834K (77)
|
Full Article (XML)-91K (16)
|
Audio-833K (12)
|
Peer-Review Report-243K (20)
|
Answering Reviewers-100K (16)
|
Received: 11/18/2024
|
Revised: 01/31/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1493)
|
Similar Articles (1716)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):103973.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103973
Abstract (161)
|
Core Tip (158)
|
Full Article (HTML) (922)
|
Full Article (PDF)-406K (73)
|
Full Article with Cover (PDF)-661K (86)
|
Full Article (XML)-95K (21)
|
Audio-989K (14)
|
Peer-Review Report-215K (19)
|
Answering Reviewers-118K (27)
|
Received: 12/05/2024
|
Revised: 01/24/2025
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1686)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy

World J Gastroenterol
31(10):104429.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.104429
Abstract (152)
|
Core Tip (134)
|
Full Article (HTML) (437)
|
Tables (1-1) (139)
|
Full Article (PDF)-366K (44)
|
Full Article with Cover (PDF)-621K (73)
|
Full Article (XML)-45K (21)
|
Audio-1658K (11)
|
Peer-Review Report-175K (18)
|
Answering Reviewers-38K (26)
|
Received: 12/19/2024
|
Revised: 01/13/2025
|
Accepted: 01/24/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (1315)
|
Similar Articles (1766)
|
Timeline of Article Publication (0)
|
Authors Evaluation (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open